Following the withdrawal of rofecoxib and valdecoxib, the discussion concerning selective cyclo-oxygenase (COX)-2 inhibitors was often characterized more by emotions than scientific evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback